These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 201214)

  • 1. Polymyxin B and rifampin: new regimen for multiresistant Serratia marcescens infections.
    Ostenson RC; Fields BT; Nolan CM
    Antimicrob Agents Chemother; 1977 Dec; 12(6):655-9. PubMed ID: 201214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of polymyxin B nonapeptide to augment bactericidal activities of novobiocin, rifampin, and of defibrinated human blood against Serratia marcescens.
    Traub WH; Kohl KH; Spohr M; Bauer D
    Chemotherapy; 1988; 34(3):195-201. PubMed ID: 2843325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro additive effect of polymxin B and rifampin against Serratia marcesen.
    Traub WH; Kleber I
    Antimicrob Agents Chemother; 1975 Jun; 7(6):874-6. PubMed ID: 168807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of the colistin disk test in identification of Serratia marcescens and Serratia liquefaciens.
    von Graevenitz A; Zollinger-Iten J
    Eur J Clin Microbiol; 1987 Feb; 6(1):70-1. PubMed ID: 3032610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of polysaccharide components in polymyxin B treated cells of Serratia marcescens.
    Weber DA; Nadakavukaren MJ; Tsang JC
    J Antibiot (Tokyo); 1978 Jul; 31(7):732-5. PubMed ID: 211111
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro activity of polymyxin B plus imipenem, meropenem, or tigecycline against KPC-2-producing Enterobacteriaceae with high MICs for these antimicrobials.
    Barth N; Ribeiro VB; Zavascki AP
    Antimicrob Agents Chemother; 2015; 59(6):3596-7. PubMed ID: 25801560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymyxin B-induced cocarde growth phenomenon of Serratia marcescens due to cationic detergent-like activity of polymyxin B.
    Traub WH
    Chemotherapy; 1982; 28(5):363-8. PubMed ID: 6291867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electron microscopic observations of polysaccharide components in polymyxin B treated outer membranes from Serratia marcescens.
    Weber DA; Nadakavukaren MJ; Tsang JC
    J Antibiot (Tokyo); 1979 Jan; 32(1):66-72. PubMed ID: 83989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical and electrophoretic changes induced by polymyxin B on outer membrane components from Serratia marcescens.
    Brown DA; Tsang JC
    J Antibiot (Tokyo); 1978 Jun; 31(6):603-9. PubMed ID: 210151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii.
    Yoon J; Urban C; Terzian C; Mariano N; Rahal JJ
    Antimicrob Agents Chemother; 2004 Mar; 48(3):753-7. PubMed ID: 14982760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of polymyxin B on the synthesis of prodigiosin and its precursors in Serratia marcescens.
    Tsang JC; Feng JS
    J Antibiot (Tokyo); 1983 Nov; 36(11):1564-6. PubMed ID: 6317625
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo potentiation of the action of polymyxin B by gramicidin Dubos.
    Radhakrishna G; Ramachandran LK
    Indian J Exp Biol; 1981 Jan; 19(1):57-60. PubMed ID: 6165682
    [No Abstract]   [Full Text] [Related]  

  • 13. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City.
    Quale J; Shah N; Kelly P; Babu E; Backer M; Rosas-Garcia G; Salamera J; George A; Bratu S; Landman D
    Microb Drug Resist; 2012 Apr; 18(2):132-6. PubMed ID: 22196342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of polymyxin B on outer membranes of Serratia marcescens: morphological alterations of the outer membranes and their lipopolysaccharide components.
    Weber DA; Nadakavukaren MJ; Tsang JC
    Microbios; 1976; 17(68-69):149-61. PubMed ID: 200827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of polymyxin B on kappa phage adsorption on Serratia marcescens HY.
    Patel KA; Patel IR; Mehta AM; Dave PJ
    Indian J Exp Biol; 1980 Nov; 18(11):1353-4. PubMed ID: 6260637
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement by polymyxin B of proline-induced prodigiosin biosynthesis in non-proliferating cells of Serratia marcescens.
    Lauferska U; Viñas M; Lorén JG; Guinea J
    Microbiologica; 1983 Apr; 6(2):155-62. PubMed ID: 6306401
    [No Abstract]   [Full Text] [Related]  

  • 17. Serratia marcescens arn, a PhoP-regulated locus necessary for polymyxin B resistance.
    Lin QY; Tsai YL; Liu MC; Lin WC; Hsueh PR; Liaw SJ
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5181-90. PubMed ID: 24957827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic characterization and in vitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapenems.
    Zhang R; Cai JC; Zhou HW; Nasu M; Chen GX
    J Med Microbiol; 2011 Dec; 60(Pt 12):1813-1819. PubMed ID: 21835972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of a synergistic combination of cefotaxime and amikacin against multiresistant Pseudomonas and Serratia infections.
    Maslow MJ; Simberkoff MS; Rahal JJ
    J Antimicrob Chemother; 1985 Aug; 16(2):227-34. PubMed ID: 3934125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy of imipenem--a novel carbapenem, and rifampin and ciprofloxacin against Pseudomonas aeruginosa, Serratia marcescens and Enterobacter species.
    Chin NX; Neu HC
    Chemotherapy; 1987; 33(3):183-8. PubMed ID: 3109815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.